Study of Irinotecan on a Weekly Schedule in Children
NCT00062842
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
23
Enrollment
OTHER
Sponsor class
Conditions
Cancer
Interventions
DRUG:
Irinotecan
Sponsor
Baylor College of Medicine